RUDRA Registry (Real-World Clinical Registry for Patients With Recurrent Pericarditis)
NCT Number: NCT06517966
Status: NOT_YET_RECRUITING
Study Type: OBSERVATIONAL
Conditions: Pericarditis
Sponsor: Eurasian Association of Therapists
Sex: ALL
Age: ADULT, OLDER_ADULT
Enrollment: 100
Study Design: Observational Model: |Time Perspective: p
Start Date: 2024-09-01
Completion Date: 2027-10-31

Summary:
А multicenter, non-interventional real world clinical registry of patients with recurrent pericarditis.

The main goal of the registry is to epidemiologically assess the pattern, clinical outcomes, and approaches to therapy in patients with recurrent pericarditis.

Primary Outcome Measures: Number of pericarditis recurrences, according to the 2022 nation criteria: intermittent or intermittent (with asymptomatic periods without the use of therapy for more than 6 weeks); continuous-relapsing (discontinuation or reduction in the intensity of anti-inflammatory therapy results in relapse in less than 6 weeks, 6, 12, 18, 24, 30, 36 month
Secondary Outcome Measures: Number of participants with therapy changes during the past period, Determining therapy changes in patients with recurrent pericarditis at each visit (6, 12, 18, 24, 30, 36 month), 6, 12, 18, 24, 30, 36 month|Hospitalization for any reason, To estimate hospitalization for any reason at each visit (6, 12, 18, 24, 30, 36 month) in a cohort of patients with recurrent pericarditis, 6, 12, 18, 24, 30, 36 month|Hospitalization due to pericarditis, To estimate hospitalization due to pericarditis at each visit (6, 12, 18, 24, 30, 36 month) in a cohort of patients with recurrent pericarditis, 6, 12, 18, 24, 30, 36 month|Hospitalization for another cardiac cause, To estimate hospitalization for another cardiac cause at each visit (6, 12, 18, 24, 30, 36 month) in a cohort of patients with recurrent pericarditis, 6, 12, 18, 24, 30, 36 month|Death from any cause, To estimate death from any cause at each visit (6, 12, 18, 24, 30, 36 month) in a cohort of patients with recurrent pericarditis, 6, 12, 18, 24, 30, 36 month|Death due to cardiac cause, To estimate death due to cardiac cause at each visit (6, 12, 18, 24, 30, 36 month) in a cohort of patients with recurrent pericarditis, 6, 12, 18, 24, 30, 36 month|Cardiovascular events (STEMI, MI, TIA, etc.), To assess the development of cardiovascular events in patients with recurrent pericarditis at each visit (6, 12, 18, 24, 30, 36 month), 6, 12, 18, 24, 30, 36 month|Development of complications of recurrent pericarditis (constrictive pericarditis, cardiac tamponade, etc.), To assess the development of complications of recurrent pericarditis in patients with recurrent pericarditis at each visit (6, 12, 18, 24, 30, 36 month), 6, 12, 18, 24, 30, 36 month|Quality of life (prospective branch only), To assess the quality of life of patients with recurrent pericarditis. The quality of life will be assessed using the SF-12 short form, consisting of 12 questions. A low quality of life corresponds to scores of 36-47 points, medium to 24-35 points, and high to 12-23 points., 0, 12, 24, 36 month|Pain scale (prospective branch only), To assess the level of pain (on a pain scale) of patients with recurrent pericarditis. The pain syndrome will be assessed using the Visual Analog Scale, where 10 points indicate unbearable pain and 0 points indicate no pain., 0, 12, 24, 36 month